The Danish company’s share price rise of 7 per cent this year lags far behind its rival Eli Lilly’s 36 per cent, as the US company has gradually increased its share of the obesity and diabetes market ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo ...

AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial.

Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The news sent the stock sharply ...

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...

Take Roche. It re-entered the battle for a weight loss pill last year through its acquisition of California’s Carmot Therapeutics for up to $3.1bn. Roche’s chief executive Thomas Schinecker ...

The Swiss pharma company Roche is developing an oral GLP-1 weight ... to develop weight loss treatments as a once-daily oral pill. It is believed that this method could expand the market for ...

Speaking to the press Wednesday, Roche’s chief executive Thomas Schinecker critiqued the proposed transaction, arguing that it could hamper the ability of smaller biopharma players to lock down ...

While labels on over-the-counter (OTC) erection pills and products may hint they are just like Viagra (sildenafil) or another erectile dysfunction (ED) drug, their benefits remain largely unproven.

The proposed rule would mandate that health plans cover over-the-counter birth control — including daily pills, emergency contraceptives and condoms. “While we fight to protect and expand ...